CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,010.00
+5.00 (0.25%)
Mar 28, 2025, 3:30 PM KST
-11.45%
Market Cap 279.17B
Revenue (ttm) 99.10B
Net Income (ttm) 2.69B
Shares Out 138.89M
EPS (ttm) 5.00
PE Ratio 103.60
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 931,712
Average Volume 1,006,416
Open 2,015.00
Previous Close 2,005.00
Day's Range 1,973.00 - 2,035.00
52-Week Range 1,590.00 - 2,525.00
Beta 0.66
RSI 63.34
Earnings Date Mar 21, 2025

About CMG Pharmaceutical

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutic... [Read more]

Sector Healthcare
Founded 2001
Employees 273
Stock Exchange KOSDAQ
Ticker Symbol 058820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.